Clinical presentation and prognosis in MOG-antibody disease: a UK study
Maciej Juryńczyk(John Radcliffe Hospital), Jacqueline Palace(Mayo Clinic), Naheed Raza(John Radcliffe Hospital), Gavin L Reynolds(John Radcliffe Hospital), George Tackley(John Radcliffe Hospital), Saleel Chandratre(John Radcliffe Hospital), Mark Woodhall(John Radcliffe Hospital), Patrick Waters(University of Oxford), Adriana Roca‐Fernández(National Health Service), Cheryl Hemingway(Great Ormond Street Hospital), Angela Vincent(University of Oxford), Shahd Hamid(University of Liverpool), Maria Isabel Leite(Mayo Clinic), Silvia Messina(John Radcliffe Hospital), Angela Sheard(John Radcliffe Hospital), Anu Jacob(University of Liverpool), Rosie Everett(John Radcliffe Hospital)
Cited by 729
Related Papers
A clinical approach to diagnosis of autoimmune encephalitis
|The Lancet Neurology|2016|4.4k
Serologic diagnosis of NMO
|Neurology|2012|526
Serial Anti–Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes
|JAMA Neurology|2019|326
The Neuromuscular Junction in Health and Disease: Molecular Mechanisms Governing Synaptic Formation and Homeostasis
|Frontiers in Molecular Neuroscience|2020|185
Randomized Placebo‐Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy
|Annals of Neurology|2019|159